Wall Street Zen Upgrades Bio-Rad Laboratories (NYSE:BIO) to “Buy”
Bio-Rad Laboratories (NYSE:BIO – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued on Saturday. Other research analysts also recently issued reports about the company. Wells Fargo & Company cut their price target on Bio-Rad Laboratories from $320.00 to […]
